Atle Fund Management AB

Position in BSX — Boston Scientific Corp

CIK 1381843 STOCKHOLM, V7

Position in BSX

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$6,247,541

+$3,710,433 QoQ

Shares Held

146,381

+262.0% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

1.68%

of 13F equity value

Holder Rank

#383

of 1,468 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Atle Fund Management AB holds $36,394,285 across 5 Medical Devices names. BSX ranks #4 (17.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	30,283	$9,534,299
2	EW	Edwards Lifesciences Corp	103,230	$9,338,185
3	IRTC	iRhythm Holdings, Inc.	54,102	$6,435,432
4	BSX	Boston Scientific Corp This page	146,381	$6,247,541
5	DXCM	Dexcom Inc	71,846	$4,838,828

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,247,541	146,381	+262.0%	Shares	Sole	2026-07-24
2026-03-31	$2,537,108	40,432	-62.8%	Shares	Sole	2026-05-11
2025-12-31	$10,362,828	108,682	+25.4%	Shares	Sole	2026-02-06
2025-09-30	$898,420	86,680	-31.3%	Shares	Sole	2025-11-04
2025-06-30	$13,553,530	126,185	-4.6%	Shares	Sole	2025-07-14
2025-03-31	$13,343,700	132,273	-14.2%	Shares	Sole	2025-05-05
2024-12-31	$13,775,109	154,222	+45.3%	Shares	Sole	2025-02-04
2024-09-30	$8,897,213	106,172	-0.4%	Shares	Sole	2024-11-12
2024-06-30	$8,205,954	106,557	+37.7%	Shares	Sole	2024-08-14
2024-03-31	$5,301,194	77,401	+19.4%	Shares	Sole	2024-04-25
2023-12-31	$3,746,434	64,806	+6008.0%	Shares	Sole	2024-01-30
2022-12-31	$49,092	1,061	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.